Breaking News Instant updates and real-time market news.

AMGN

Amgen

$189.66

1.45 (0.77%)

17:11
10/30/18
10/30
17:11
10/30/18
17:11

Amgen CEO: 'newer products continue to deliver strong growth in unit volumes'

We are in the early stages of launching several new products that offer innovative solutions for patients suffering from serious diseases," said Robert Bradway, chairman and CEO. "Our newer products continue to deliver strong growth in unit volumes."

  • 30

    Oct

  • 07

    Nov

  • 09

    Nov

  • 12

    Nov

AMGN Amgen
$189.66

1.45 (0.77%)

10/29/18
PIPR
10/29/18
NO CHANGE
PIPR
Neutral
Piper sees Amgen's Aimovig pressuring Allergan's Botox in near term
Piper Jaffray analyst Christopher Raymond keeps an Overweight rating on Amgen (AMGN) and Neutral rating on Allergan (AGN) after his firm's Overweight based on feedback from a migraine survey fielded by his firm's partner Spherix Global Insights. The analyst is "struck by the progress" Amgen has made just months into Aimovig's launch, specifically on sales coverage, message delivery and overall credibility with physicians. It appears that Allergan's Botox "could be in for some pressure in the near term at the direct hands" of Amgen's Aimovig, Raymond tells investors in a research note titled "Aiming for Aimovig; New Migraine Survey Indicates Aimovig the Star of the Show." Doctors are projecting peak Aimovig share of 49% and 29% for chronic and episodic patients respectively, which infers peak U.S. revenue for the drug at $3.3B, the analyst says. Further, he notes that of the 98 high volume migraine specialists surveyed, 43% versus 29% agreed with the statement: "I am more likely to prescribe Aimovig over Botox due to access to patient assistance program."
10/25/18
MSCO
10/25/18
NO CHANGE
Target $212
MSCO
Overweight
Repatha list price cut has benefits for Amgen, says Morgan Stanley
Morgan Stanley analyst Matthew Harrison noted that Amgen announced that it is reducing Repatha's list price by 60%, stating that he believes the new list price of $5,850/year is similar to the current net price for the treatment. He also noted that Amgen management said they anticipate little impact to long-term blended net price, though there could be some volatility in the near-term. Given the current political environment, he sees two key benefits to the strategy, namely that it is "a novel SKU strategy" and second the lower price likely improves a structural headwind since Repatha is largely a Medicare product. Harrison keeps an Overweight rating on Amgen shares.
10/01/18
CANT
10/01/18
INITIATION
Target $223
CANT
Neutral
Amgen initiated with a Neutral at Cantor Fitzgerald
Cantor Fitzgerald analyst Alethia Young started Amgen with a Neutral rating and $223 price target.
09/28/18
WELS
09/28/18
NO CHANGE
WELS
Market Perform
Lilly's migraine treatment approval adds to Teva worries, says Wells Fargo
Wells Fargo analyst David Maris noted that Eli Lilly (LLY) received FDA approval of Emgality for the prevention of migraines and announced a U.S. list price of $6,900 annually, which is in line with Teva's (TEVA) Ajovy and Aimovig from Amgen (AMGN) and Novartis (NVS). Lilly's approval adds to Teva investor worries, said Maris, who sees migraines being a competitive market with similar drugs "where the competitors are marketing powerhouses...and Teva is undergoing a lot of organizational change." He maintains a Market Perform rating on Teva shares.

TODAY'S FREE FLY STORIES

09:45
08/21/19
08/21
09:45
08/21/19
09:45
General news
Existing Home Sales to be reported at 10:00 »

July Existing Home Sales…

KSS

Kohl's

$44.87

(0.00%)

09:42
08/21/19
08/21
09:42
08/21/19
09:42
Recommendations
Kohl's analyst commentary  »

Kohl's [price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$210.35

(0.00%)

, AMGN

Amgen

$203.15

(0.00%)

09:41
08/21/19
08/21
09:41
08/21/19
09:41
Periodicals
Apple, Amgen, Cisco all slowed buyback spending in Q2, WSJ says »

S&P Dow Jones Indices…

AAPL

Apple

$210.35

(0.00%)

AMGN

Amgen

$203.15

(0.00%)

CSCO

Cisco

$47.94

(0.00%)

BAC

Bank of America

$26.72

(0.00%)

ORCL

Oracle

$53.00

(0.00%)

JPM

JPMorgan

$107.33

(0.00%)

WFC

Wells Fargo

$44.70

(0.00%)

MSFT

Microsoft

$137.25

(0.00%)

JCI

Johnson Controls

$42.34

(0.00%)

GOOGL

Alphabet Class A

$1,184.26

(0.00%)

GOOG

Alphabet

$1,183.43

(0.00%)

C

Citi

$63.44

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 04

    Sep

  • 04

    Sep

  • 06

    Sep

  • 09

    Sep

  • 09

    Sep

  • 10

    Sep

  • 16

    Sep

  • 19

    Sep

  • 24

    Sep

  • 10

    Oct

  • 12

    Oct

  • 15

    Oct

  • 15

    Oct

  • 15

    Oct

  • 16

    Oct

  • 27

    Oct

  • 13

    Nov

URBN

Urban Outfitters

$20.93

(0.00%)

, LOW

Lowe's

$98.04

(0.00%)

09:40
08/21/19
08/21
09:40
08/21/19
09:40
Options
Unusually active option classes on open August 21st »

Unusual total active…

URBN

Urban Outfitters

$20.93

(0.00%)

LOW

Lowe's

$98.04

(0.00%)

PDD

Pinduoduo

$25.97

(0.00%)

FIT

Fitbit

$2.94

(0.00%)

FCX

Freeport McMoRan

$9.19

(0.00%)

HD

Home Depot

$217.14

(0.00%)

TLRY

Tilray

$29.30

(0.00%)

RIG

Transocean

$4.58

(0.00%)

XBI

SPDR S&P BIOTECH

$82.47

(0.00%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 21

    Aug

  • 21

    Aug

  • 22

    Aug

  • 10

    Sep

  • 23

    Sep

  • 25

    Sep

  • 19

    Nov

  • 19

    Nov

CLR

Continental Resources

$30.57

-0.65 (-2.08%)

09:39
08/21/19
08/21
09:39
08/21/19
09:39
Recommendations
Continental Resources analyst commentary  »

Continental Resources…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVRO

Nevro

$82.98

2.13 (2.63%)

09:37
08/21/19
08/21
09:37
08/21/19
09:37
Conference/Events
Nevro participates in a conference call with SVB Leerink »

SVB Leerink holds a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Aug

  • 09

    Sep

TGT

Target

$85.57

-0.34 (-0.40%)

09:36
08/21/19
08/21
09:36
08/21/19
09:36
Options
Pre-earnings call sale in Target turns ugly as shares jump »

Pre-earnings call sale in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 15

    Sep

  • 19

    Sep

  • 25

    Sep

PAVM

PAVmed

$1.00

(0.00%)

09:33
08/21/19
08/21
09:33
08/21/19
09:33
Hot Stocks
PAVmed announces issuance of U.S. patent »

PAVmed announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RECN

Resources Connection

$16.66

-0.06 (-0.36%)

09:32
08/21/19
08/21
09:32
08/21/19
09:32
Hot Stocks
RGP sell assets of local Nordics business to Capacent »

Resources Connection…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

URBN

Urban Outfitters

$20.93

0.07 (0.34%)

09:31
08/21/19
08/21
09:31
08/21/19
09:31
Recommendations
Urban Outfitters analyst commentary at MKM Partners »

Urban Outfitters price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

  • 25

    Sep

  • 19

    Nov

TS

Tenaris

$21.31

-0.495 (-2.27%)

09:30
08/21/19
08/21
09:30
08/21/19
09:30
Upgrade
Tenaris rating change  »

Tenaris upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PRSP

Perspecta

$24.92

0.375 (1.53%)

09:27
08/21/19
08/21
09:27
08/21/19
09:27
Hot Stocks
Perspecta awarded $1M DARPA to provide AI compact hardware research »

Perspecta's applied…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RRGB

Red Robin

$32.87

1.05 (3.30%)

09:27
08/21/19
08/21
09:27
08/21/19
09:27
Recommendations
Red Robin analyst commentary  »

Stephens supportive of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

URBN

Urban Outfitters

$20.93

0.07 (0.34%)

09:22
08/21/19
08/21
09:22
08/21/19
09:22
Recommendations
Urban Outfitters analyst commentary at Loop Capital »

Urban Outfitters price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

  • 25

    Sep

  • 19

    Nov

LSI

Life Storage

$103.32

-0.13 (-0.13%)

, PSA

Public Storage

$260.45

-0.6 (-0.23%)

09:21
08/21/19
08/21
09:21
08/21/19
09:21
Upgrade
Life Storage, Public Storage rating change  »

Life Storage upgraded to…

LSI

Life Storage

$103.32

-0.13 (-0.13%)

PSA

Public Storage

$260.45

-0.6 (-0.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VSTO

Vista Outdoor

$4.90

0.18 (3.81%)

09:20
08/21/19
08/21
09:20
08/21/19
09:20
Recommendations
Vista Outdoor analyst commentary  »

Vista Outdoor would be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

  • 19

    Sep

PSA

Public Storage

$260.45

-0.6 (-0.23%)

, LSI

Life Storage

$103.32

-0.13 (-0.13%)

09:20
08/21/19
08/21
09:20
08/21/19
09:20
Upgrade
Public Storage, Life Storage rating change  »

Public Storage upgraded…

PSA

Public Storage

$260.45

-0.6 (-0.23%)

LSI

Life Storage

$103.32

-0.13 (-0.13%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DXCM

DexCom

$168.11

4.6 (2.81%)

09:18
08/21/19
08/21
09:18
08/21/19
09:18
Conference/Events
DexCom participates in a conference call with SVB Leerink »

SVB Leerink holds a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Aug

  • 09

    Sep

  • 13

    Nov

SPX

S&P 500

$0.00

(0.00%)

, VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

09:18
08/21/19
08/21
09:18
08/21/19
09:18
Options
Overnight activity included 766 trades in SPX and 10 trades in VIX »

766 trades were executed…

SPX

S&P 500

$0.00

(0.00%)

VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ASGN

ASGN

$62.17

-0.17 (-0.27%)

, GOOGL

Alphabet Class A

$1,184.26

-15.68 (-1.31%)

09:17
08/21/19
08/21
09:17
08/21/19
09:17
Hot Stocks
ASGN segment named Google cloud platform premier partner »

ECS, a segment of ASGN…

ASGN

ASGN

$62.17

-0.17 (-0.27%)

GOOGL

Alphabet Class A

$1,184.26

-15.68 (-1.31%)

GOOG

Alphabet

$1,183.43

-14.58 (-1.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

  • 05

    Sep

  • 10

    Sep

  • 24

    Sep

  • 27

    Oct

LOW

Lowe's

$98.04

3.07 (3.23%)

09:16
08/21/19
08/21
09:16
08/21/19
09:16
Hot Stocks
Lowe's says average ticket grew 2% in Q2 »

Says: Pro sales…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 25

    Sep

BRPA

Big Rock Partners Acquisition

$10.48

0.01 (0.10%)

09:13
08/21/19
08/21
09:13
08/21/19
09:13
Conference/Events
Big Rock Partners Acquisition to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

EA

Electronic Arts

$92.70

1.8 (1.98%)

09:12
08/21/19
08/21
09:12
08/21/19
09:12
Recommendations
Electronic Arts analyst commentary at Stephens »

Apex players seem…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 13

    Nov

FIT

Fitbit

$2.94

0.01 (0.34%)

09:11
08/21/19
08/21
09:11
08/21/19
09:11
Hot Stocks
Fitbit announces collaboration with Singapore's Health Promotion Board »

Fitbit announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

TJX

TJX

$51.55

(0.00%)

09:11
08/21/19
08/21
09:11
08/21/19
09:11
Recommendations
TJX analyst commentary at Loop Capital »

TJX Q2 results 'not…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.